
- Mount Sinai Doctors
- Treats Adults
- Video Visit Available
- Accepting New Patients
Adam F Steinlauf, MD
Gastroenterology
About Me
Dr. Steinlauf received his B.A. from Brandeis University. He graduated Cum Laude in 1987 and was elected to the Phi Beta Kappa honor society. He received his medical degree from the State University of New York Health Science Center at Brooklyn (Downstate Medical School), and graduated Cum Laude in 1991. He received his residency training in the department of Internal Medicine at Columbia-Presbyterian Medical Center from 1991-1994. After completing his residency training, he was appointed Assistant Clinical Professor of Medicine at Columbia University School of Medicine and Assistant Attending, Columbia-Presbyterian Medical Center from 1994-1995 where he practiced Internal Medicine. He then received his Gastroenterology fellowship training at Yale University from 1995-1998. From 1998-2001, Dr. Steinlauf was in private practice in New Jersey, and in 2001, he joined the gastroenterology practice of Drs. Daniel Present, Mark Chapman, and James Marion.
Dr. Steinlauf is fully trained in all aspects of gastroenterology but subspecializes in the diagnosis and treatment of the inflammatory bowel diseases (IBD), ulcerative colitis and Crohn's disease. In addition, Dr. Steinlauf is extensively involved in the study of new and exciting research protocols which will hopefully lead to a better understanding of IBD and improve on current management strategies.
Language
English
Position
PROFESSOR | Medicine, Gastroenterology
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- Colon Polypectomy
- Colon Polyps
- Colonoscopy
- Crohn's Disease
- Flexible Sigmoidoscopy
- Inflammatory Bowel Disease
- Iron-Deficiency Anemia
- Short Bowel Syndrome
- Ulcerative Colitis
- Upper GI Endoscopy
Education
MD, SUNY Downstate Health Sciences University - College of Medicine
Internship, Internal Medicine
Columbia University Irving Medical Center
Residency, Internal Medicine
Columbia Presbyterian Medical Center
Fellowship, Gastroenterology
Yale New Haven Children's Hospital
Certifications
American Board of Internal Medicine
Research
Current protocols in progress for Ulcerative Colitis include: Rosiglitazone, the probiotic VSL#3, Visilizumab, and Luekocytapharesis.
Current protocols for in progress for Crohn -?s disease include: extracorporeal photoimmune therapy with UVADEX, Sargrostim (Leukine), anti-IL-12, Adalimumab, Visilizumab and high dose asacol.
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - Medicare
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Multiplan PHCS
- Oscar
- Oxford - Freedom and Liberty
- Partners Health Plan
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn's Disease: A Post Hoc Analysis of 3 Phase 3 Trials. Jean Frédéric Colombel, Ana P. Lacerda, Peter M. Irving, Remo Panaccione, Walter Reinisch, Florian Rieder, Adam Steinlauf, David Schwartz, Tian Feng, Elena Dubcenco, Samuel I. Anyanwu, F. Stephen Laroux, Colla Cunneen, Nick Powell. Clinical Gastroenterology and Hepatology
- Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn's Disease. Subrata Ghosh, Brian G. Feagan, Rogério Serafim Parra, Susana Lopes, Adam Steinlauf, Yoichi Kakuta, Namita Joshi, Wan Ju Lee, Ana P. Lacerda, Qian Zhou, Si Xuan, Kristina Kligys, Nidhi Shukla, Edouard Louis. Journal of Crohn's and Colitis
- Overview of Biosimilars in Inflammatory Bowel Diseases. Linda A. Feagins, Stephanie Gold, Adam F. Steinlauf. American Journal of Gastroenterology
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
Care Provider’s Concern
Likelihood to Recommend Care Provider
Dr. Steinlauf is an excellent doctor. He is very thorough and explains everything in detail. He will Inform you of any blood work and procedures that may be needed and advise you on what's the best treatment.
Always a great experience.
So far good. I'll know if I would recommend him after more visits and outcome of results from future care received.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Steinlauf has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.